Coronary angiographic abnormalities in patients of diabetes mellitus and metabolic syndrome

Avishek Saha, Vishwa Deepak Tripathi, Madhumita Kuila, Ranjan Kumar Sharma


Background: Diabetes mellitus and Metabolic syndrome, both are established risk factors for CAD. In our study, we tried to compare the effects of these two diseases individually as well as their combined effect.

Methods: we performed an Observational, cross-sectional, hospital-based, single center study on 240 patients presenting at our hospital with chest pain. we assessed the severity of CAD with Syntax score and divided the study population into three groups with SS of <=22, 23-32 and >=33.

Results: statistically significant difference was found in each of the first three groups of combined MS plus DM, only MS without DM, only DM without MS when compared with the fourth group of nondiabetics nonmetabolic syndrome patients. Strongest difference was found between patients with combined diabetes and metabolic syndrome with those who had none of these (<0.001). Thus, complexity of CAD is much severe in patients who have diabetes and/or metabolic syndrome.

Conclusions: Patients having diabetes mellitus and/or metabolic syndrome are found to have more severe form of coronary artery disease than those who don’t have either of these. However, presence of both diabetes and metabolic syndrome has not been found to impose any significant additional risk than their isolated presence.


Diabetes mellitus, Metabolic syndrome, Syntax score

Full Text:



Kip KE, Marroquin OC, Kelley DE, Johnson BD, Kelsey SF, Shaw LJ, Rogers WJ, Reis SE. Clinical importance of obesity versus the metabolic syndrome in cardiovascular risk in women. Circulation. 2004;109(6):706-13.

Pandit K, Goswami S, Ghosh S, Mukhopadhyay P, Chowdhury S. Metabolic syndrome in south Asians. Ind j Endocrinol Metabol. 2012;16(1):44.

Mahalle N, Garg MK, Kulkarni MV, Naik SS. Differences in traditional and non-traditional risk factors with special reference to nutritional factors in patients with coronary artery disease with or without diabetes mellitus. Indian J Endocrinol Metab. 2013;17:844-50.

Konstantinou DM. The impact of age & ethnicity in coronary artery disease risk assessment using Framingham Risk Scores and metabolic syndrome. Ind J Medic Res. 2013;137(2):247.

Aykan AÇ, Gül İ, Kalaycıoğlu E, Gökdeniz T, Hatem E, Menteşe Ü, et al. Is metabolic syndrome related with coronary artery disease severity and complexity: An observational study about IDF and AHA/NHLBI metabolic syndrome definitions. Cardiolog J. 2014;21(3):245-51.

Rana JS, Dunning A, Achenbach S, Al-Mallah M, Budoff MJ, Cademartiri F, et al. Differences in prevalence, extent, severity, and prognosis of coronary artery disease among patients with and without diabetes undergoing coronary computed tomography angiography. Diabet care. 2012;35(8):1787-94.

Kip KE, Marroquin OC, Kelley DE, Johnson BD, Kelsey SF, Shaw LJ, et al. Clinical importance of obesity versus the metabolic syndrome in cardiovascular risk in women: A report from the Women's Ischemia Syndrome Evaluation (WISE) study. Circulation. 2004;109:706-13.

Yavuz B, Kabakci G, Aksoy H, Tulumen E, Deveci OS, Aytemir K, et al. Determining the relationship between metabolic syndrome score and angiographic severity of coronary artery disease. Inter J Clinic Prac. 2008;62(5):717-22.

Anuurad E, Chiem A, Pearson TA, Berglund L. Metabolic syndrome components in African-Americans and European-American patients and its relation to Coronary Artery Disease. Am J Cardiol. 2007;100:830-4.